Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatoma-derived growth factor-like 1 (HDGFL1) is a nuclear protein predicted to be involved in chromatin remodeling and is active in the nucleus[1][5]. It is related to the hepatoma-derived growth factor (HDGF) protein family but does not appear to have a well-characterized function as a classical therapeutic target; current evidence suggests roles in iron homeostasis and reproductive biology based on genetic associations, but its precise molecular functions remain incompletely understood[1][5]. HDGFL1 contains a PWWP domain, which is often implicated in chromatin binding and regulation. No direct drug interactions or established biomarker roles are currently described for this protein[1][5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatoma-derived growth factor-like 1 (HDGFL1).